Dr. Helena S. Wisniewski, Vice President, University Research and Enterprise Development for Stevens, said, "We look forward to a growing relationship with CTT. Stevens' rich IP portfolio reflects our educational environment of enterprise and innovation Technogenesis where students, faculty and partners in industry nurture new technologies from concept to commercialization. We hope that our partnership with CTT will bring the university additional revenues which will continue the expansion of our environment of innovation and enterprise."
"We are pleased to enter into this relationship with Stevens Institute to serve their ongoing technology commercialization needs," said Ted Kutrumbos, CTT Business Development Executive. "The initial set of Stevens' IP includes among others, a novel, non-invasive bone mass measurement technique, stent delivery technologies, 3D imaging systems, and athletic devices."
"This and other new relationships are central to our growth strategy. As a leading research university, Stevens has some exciting technologies and we look forward to adding them to our portfolio and bringing them to market," commented Mike Kiley, CTT's Executive VP and Chief Technology Officer. "Stevens' technologies span multiple industries and include applications for life sciences, engineering and consumer products, among others."